RxDoctor Payments Data

Arun Rajan

Internal Medicine · Bethesda, MDNPI 1316111776

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $25 of the $39 with a category attached, or 63.9%. Novartis accounts for 63.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for internal medicine clinicians in MD, where the typical reported total is $161.

$39in general payments, 2019–2025

Across 2 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$25
  • Takeda Pharmaceuticals U.S.A., Inc.$14
$551,652in research payments, 2019–2025

Across 1 payment — averaging $551,652 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$552K

What the payments were for

  • Food & beverage$2564%
  • Education$1436%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$39 in reported general payments places this provider in the 30th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Other internal medicine in Bethesda

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →